PURPOSE: RPE65 is the visual cycle retinol isomerase and missense mutations in its gene cause severe retinal dystrophies in man, due to lack of chromophore. While the rate of opsin regeneration in mouse is slower than in man, the methionine (M) variant of mouse RPE65 residue 450 (normally L) is associated with additionally lowered light sensitivity and with resistance to light damage in C57Bl/6 mice, consistent with lowered total activity. We wished to determine how this variant affects RPE65 and if it is modulated by other rodent-specific variations. METHODS: Site-directed mutagenesis was used to make variant constructs in mouse and dog RPE65, which were tested for isomerase activity by transient transfection in 293-F cells. RESULTS: The isomerase activity of dog RPE65 is slightly higher than mouse. Replacing L at aa450 with M reduces total activity of dog to approximately 70% and mouse to approximately 45% of respective wild type RPE65, and also reduces protein levels of both variants. Replacing K at aa446 in mouse with R, as in other species, reduces total activity in mouse RPE65, whereas the converse case, changing dog aa446 from R to K, increases activity. Exchanges of residues at aa457 and 459 had little overall effect. Human variants at two of these positions, L450R and T457N, had disparate effects, abolishing and augmenting activity, respectively. CONCLUSIONS: Wildtype dog RPE65 is more active than wildtype mouse RPE65, perhaps partially explaining the slower regeneration rate in the mouse. The effect of Met at aa450 is more severe in mouse RPE65 than in dog. The effects of variation at residues 446 (K or R) modulate variation at aa450. The sensitivity of aa450 to change is underscored by the abolition of activity in the pathogenic human L450R mutation. These results suggest that subtle species-specific residue changes may be involved in "tuning" of RPE65 activity to required evolutionary criteria.
PURPOSE:RPE65 is the visual cycle retinol isomerase and missense mutations in its gene cause severe retinal dystrophies in man, due to lack of chromophore. While the rate of opsin regeneration in mouse is slower than in man, the methionine (M) variant of mouseRPE65 residue 450 (normally L) is associated with additionally lowered light sensitivity and with resistance to light damage in C57Bl/6 mice, consistent with lowered total activity. We wished to determine how this variant affects RPE65 and if it is modulated by other rodent-specific variations. METHODS: Site-directed mutagenesis was used to make variant constructs in mouse and dogRPE65, which were tested for isomerase activity by transient transfection in 293-F cells. RESULTS: The isomerase activity of dogRPE65 is slightly higher than mouse. Replacing L at aa450 with M reduces total activity of dog to approximately 70% and mouse to approximately 45% of respective wild type RPE65, and also reduces protein levels of both variants. Replacing K at aa446 in mouse with R, as in other species, reduces total activity in mouseRPE65, whereas the converse case, changing dog aa446 from R to K, increases activity. Exchanges of residues at aa457 and 459 had little overall effect. Human variants at two of these positions, L450R and T457N, had disparate effects, abolishing and augmenting activity, respectively. CONCLUSIONS: Wildtype dogRPE65 is more active than wildtype mouseRPE65, perhaps partially explaining the slower regeneration rate in the mouse. The effect of Met at aa450 is more severe in mouseRPE65 than in dog. The effects of variation at residues 446 (K or R) modulate variation at aa450. The sensitivity of aa450 to change is underscored by the abolition of activity in the pathogenic humanL450R mutation. These results suggest that subtle species-specific residue changes may be involved in "tuning" of RPE65 activity to required evolutionary criteria.
Authors: Ana J Chucair-Elliott; Michael H Elliott; Jiangang Wang; Gennadiy P Moiseyev; Jian-Xing Ma; Luis E Politi; Nora P Rotstein; Shizuo Akira; Satoshi Uematsu; John D Ash Journal: J Biol Chem Date: 2012-05-29 Impact factor: 5.157
Authors: Michael Danciger; Diego Ogando; Haidong Yang; Michael T Matthes; Nicole Yu; Kelly Ahern; Douglas Yasumura; Robert W Williams; Matthew M Lavail Journal: Invest Ophthalmol Vis Sci Date: 2008-03-14 Impact factor: 4.799
Authors: Elliot H Choi; Susie Suh; Christopher L Sander; Christian J Ortiz Hernandez; Elizabeth R Bulman; Nimesh Khadka; Zhiqian Dong; Wuxian Shi; Krzysztof Palczewski; Philip D Kiser Journal: Hum Mol Genet Date: 2018-07-01 Impact factor: 6.150
Authors: Birgit Lorenz; Eugenia Poliakov; Maria Schambeck; Christoph Friedburg; Markus N Preising; T Michael Redmond Journal: Invest Ophthalmol Vis Sci Date: 2008-07-03 Impact factor: 4.799
Authors: Alexander V Kolesnikov; Peter H Tang; Ryan O Parker; Rosalie K Crouch; Vladimir J Kefalov Journal: J Neurosci Date: 2011-05-25 Impact factor: 6.167